Working… Menu
Trial record 1 of 1 for:    VBI-1901
Previous Study | Return to List | Next Study

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03382977
Recruitment Status : Active, not recruiting
First Posted : December 26, 2017
Last Update Posted : February 21, 2021
Information provided by (Responsible Party):
VBI Vaccines Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 14, 2020
Estimated Study Completion Date : June 30, 2021